S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Lockheed Martin Validates Stage 2 Motor for Next Generation Interceptor

Inside a high-vacuum chamber in Huntsville, Alabama, Lockheed Martin successfully fired the Stage 2 rocket motor for its Next Generation Interceptor, simulating the harsh conditions of low-Earth orbit to ensure the system can withstand the extreme thermal and pressure stresses of future missile defense missions.

Lockheed Martin Validates Stage 2 Motor for Next Generation Interceptor
Photo: Bio & News

The test, conducted by L3Harris Technologies, confirmed critical performance benchmarks including thrust output, chamber pressure, and combustion stability. This data serves as a pivotal bridge toward the program's upcoming Critical Design Review, keeping the project on schedule for a 2030 deployment. Christopher Jewell, vice president of the NGI program, noted that the results provide the necessary validation to finalize the interceptor’s architecture and accelerate its integration into the existing Ground-Based Midcourse Defense network.

Lockheed Martin is currently utilizing a "born-digital" design methodology to compress development timelines, replacing years of physical prototyping with rapid digital iteration. To support this pace, the company is scaling up manufacturing capabilities in Alabama with dedicated production lines and specialized tooling. These efforts, combined with a broad national supply chain, aim to bolster the nation's defense against sophisticated ballistic missile threats.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!